Federation Des Caisses Desjardins Du Quebec Aeterna Zentaris Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 14, 2024
SELL
$0.19 - $15.68 $24,558 - $2.03 Million
-129,257 Closed
0 $0
Q2 2022

Aug 14, 2024
BUY
$0.17 - $0.37 $6,800 - $14,800
40,000 Added 44.81%
129,257 $24.1 Million
Q1 2022

Aug 14, 2024
BUY
$0.33 - $0.42 $29,454 - $37,487
89,257 New
89,257 $31.4 Million
Q4 2021

Aug 30, 2024
BUY
$0.36 - $0.77 $10,800 - $23,100
30,000 Added 50.63%
89,258 $31.7 Million
Q3 2021

Aug 30, 2024
SELL
$0.59 - $0.88 $1,770 - $2,640
-3,000 Reduced 4.82%
59,258 $45.5 Million
Q2 2021

Aug 30, 2024
BUY
$0.83 - $1.14 $51,674 - $70,974
62,258 New
62,258 $54.4 Million
Q1 2021

Aug 30, 2024
SELL
$0.51 - $3.34 $996 - $6,523
-1,953 Reduced 4.2%
44,533 $50.6 Million
Q4 2020

Aug 30, 2024
BUY
$0.3 - $0.44 $120 - $176
400 Added 0.87%
46,486 $19.5 Million
Q3 2020

Aug 30, 2024
BUY
$0.34 - $0.55 $2,889 - $4,673
8,498 Added 22.61%
46,086 $16.1 Million
Q1 2020

Aug 30, 2024
SELL
$0.42 - $1.44 $51 - $175
-122 Reduced 0.32%
37,588 $19.2 Million
Q4 2019

Aug 30, 2024
BUY
$0.77 - $1.08 $87 - $122
113 Added 0.3%
37,710 $34.1 Million
Q3 2019

Aug 30, 2024
BUY
$1.0 - $2.97 $4,900 - $14,553
4,900 Added 14.99%
37,597 $38.8 Million
Q2 2019

Aug 30, 2024
SELL
$2.04 - $5.43 $14 - $38
-7 Reduced 0.02%
32,697 $96.1 Million
Q1 2019

Aug 30, 2024
SELL
$3.03 - $4.65 $21 - $32
-7 Reduced 0.02%
32,704 $151 Million
Q4 2018

Aug 30, 2024
BUY
$1.3 - $3.87 $42,524 - $126,591
32,711 New
32,711 $95.8 Million
Q3 2018

Aug 30, 2024
SELL
$1.6 - $2.03 $408 - $517
-255 Reduced 0.76%
33,219 $57.7 Million
Q2 2018

Aug 30, 2024
SELL
$1.19 - $2.62 $5,946 - $13,092
-4,997 Reduced 12.99%
33,474 $65 Million
Q1 2018

Aug 30, 2024
BUY
$1.46 - $2.41 $4,372 - $7,217
2,995 Added 8.44%
38,471 $56.2 Million
Q3 2017

Aug 30, 2024
SELL
$1.81 - $2.23 $52,520 - $64,707
-29,017 Reduced 44.99%
35,476 $72 Million
Q2 2017

Aug 30, 2024
BUY
N/A
39,451 Added 157.54%
64,493 $64.1 Million
Q1 2017

Aug 30, 2024
BUY
N/A
25,042
25,042 $75.1 Million

About Aeterna Zentaris Inc.

AEZS Quotes by TradingView
  • Ticker AEZS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,855,880
  • Market Cap $19.4M
  • Description
  • Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...
More about AEZS
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email